The pharmaceutical industry -- The biotechnology industry -- Generics and biosimilars -- The global pharmaceutical industry -- The demand for pharmaceuticals -- The demand for pharmaceuticals in major international markets -- Pharmaceutical prices -- Economic evaluation of new drugs -- Pricing...

When the Medicare program was created in 1965, outpatient prescription drugs were left out of the benefit package, a decision that maintained consistency with standard private insurance plans of the time. Cost was one factor behind the exclusion, but a more fundamental reason related to the role...

1. Policy process / Alan Lyles -- 2. Federal legislative process / Valerie Heitshusen -- 3. Role of federal regulations and how they are developed / Curtis W. Copeland -- 4. Access, quality, and cost / Julie A. Schmittdiel and Marsha Raebel -- 5. Why is medication use less than appropriate? /...

The recent decline in gross domestic product (GDP) growth in India raised a debate about whether it is a trend or a business cycle slowdown. We observe a cyclical downturn post-global financial crisis due to external and domestic conditions. With global recovery strengthening and appropriate...

With the revival of global economy, the issues of exit policies and rebalancing global growth have taken center stage in policy discussions. Since many emerging Asian economies presently have large current account surpluses, the issue of rebalancing has special significance for Asia. While...